UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Theranostics with somatostatin receptor antagonists in SCLC: Correlation of 68Ga-SSO120 PET with immunohistochemistry and survival

Theranostics, 2024-08, Vol.14 (14), p.5400-5412

2024

Volltextzugriff (PDF)

Fibroblast Activation Protein-Directed Imaging Outperforms 18 F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial

Journal of Nuclear Medicine, 2024-08, Vol.65 (8), p.1188-1193

2024

Volltextzugriff (PDF)

C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy

Scientific reports, 2024-06, Vol.14 (1), p.13765-12

2024

Volltextzugriff (PDF)

Patient‐reported outcomes in advanced NSCLC before and during the COVID‐19 pandemic: Real‐world data from the German prospective CRISP Registry (AIO‐TRK‐0315)

International journal of cancer, 2024-06, Vol.154 (11), p.1967-1978

2024

Volltextzugriff (PDF)

History Can Teach Us Something: Angiogenesis Inhibition Revisited

Journal of thoracic oncology, 2024-06, Vol.19 (6), p.849-851

2024

Volltextzugriff (PDF)

The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer

Journal of thoracic oncology, 2024-05, Vol.19 (5), p.786-802

2024

Volltextzugriff (PDF)

Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment-Comparison with Stage III Disease

Cancers, 2024-03, Vol.16 (6), p.1174

2024

Volltextzugriff (PDF)

Konzepte beim oligometastasierten Lungenkarzinom

Wiener klinisches Magazin : Beilage zur Wiener klinischen Wochenschrift, 2023-11, Vol.26 (5-6), p.202-211

2023

Volltextzugriff (PDF)

68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study

The Journal of nuclear medicine (1978), 2023-10, Vol.64 (10), p.1540-1549

2023

Volltextzugriff (PDF)

68 Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study

Journal of Nuclear Medicine, 2023-10, Vol.64 (10), p.1540-1549

2023

Volltextzugriff (PDF)

IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer

Journal of thoracic oncology, 2023-05, Vol.18 (5), p.564-575

2023

Volltextzugriff (PDF)

Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry

The European respiratory journal, 2023-02, Vol.61 (2), p.2201336

2023

Volltextzugriff (PDF)

Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT

Scientific reports, 2022-10, Vol.12 (1), p.17511-17511, Article 17511

2022

Volltextzugriff (PDF)

Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer: focus on treatment selection and prognostic factors

Immunotherapy, 2022-08, Vol.14 (12), p.927-944

2022

Volltextzugriff (PDF)

Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment

Radiation oncology (London, England), 2022-07, Vol.17 (1), p.126-14, Article 126

2022

Volltextzugriff (PDF)

Therapie früher und lokal fortgeschrittener Stadien des nicht-kleinzelligen Lungenkarzinoms

Die Innere Medizin, 2022-07, Vol.63 (7), p.717-723

2022

Volltextzugriff (PDF)

Treatment of early and locally advanced stages of non-small cell lung cancer

Innere Medizin (Heidelberg, Germany), 2022-07, Vol.63 (7), p.717-723

2022

Volltextzugriff (PDF)

Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications

Lung cancer (Amsterdam, Netherlands), 2022-06, Vol.168, p.10-20

2022

Volltextzugriff (PDF)

Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non–Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy

Journal of Nuclear Medicine, 2021-12, Vol.62 (12), p.1684-1691

2021

Volltextzugriff (PDF)

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18 F-FDG PET/CT for radiotherapy target volume definition

Radiation oncology (London, England), 2021-09, Vol.16 (1), p.176

2021

Volltextzugriff (PDF)

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition

Radiation oncology (London, England), 2021-09, Vol.16 (1), p.1-176, Article 176

2021

Volltextzugriff (PDF)

Acquired Resistance to BRAF/MEK Inhibitor Therapy in BRAF-V 600 -mutated Squamous Cell Lung Cancer: Concurrent Evolvement of PTEN and MEK1 Mutations

Clinical lung cancer, 2021-09, Vol.22 (5), p.e668

2021

Volltextzugriff (PDF)

Acquired Resistance to BRAF/MEK Inhibitor Therapy in BRAF-V600-mutated Squamous Cell Lung Cancer: Concurrent Evolvement of PTEN and MEK1 Mutations

Clinical lung cancer, 2021-09, Vol.22 (5), p.e668-e672

2021

Volltextzugriff (PDF)

N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [18F]FDG PET/CT compared to the histopathology reference standard

EJNMMI research, 2021-07, Vol.11 (1), p.68-68, Article 68

2021

Volltextzugriff (PDF)

1 – 25 von 132

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(126)

Publikationsform

Artikel
(131)
Tagungsberichte
(1)

Sprache

Englisch
(127)
Deutsch
(4)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(101)
Life Sciences & Biomedicine
(98)
Oncology
(87)
Humans
(85)
Lung Neoplasms - Pathology
(50)
Male
(49)
Female
(48)
Middle Aged
(43)
Aged
(40)
Respiratory System
(40)
Lung Cancer
(37)
Adult
(34)
Lung Neoplasms - Drug Therapy
(34)
Neoplasm Staging
(34)
Carcinoma, Non-Small-Cell Lung - Pathology
(31)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(28)
Tumors
(26)
Prognosis
(25)
Aged, 80 And Over
(23)
Biological And Medical Sciences
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Theranostics with somatostatin receptor antagonists in SCLC: Correlation of 68Ga-SSO120 PET with immunohistochemistry and survival

Fibroblast Activation Protein-Directed Imaging Outperforms 18 F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial

C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy

Patient‐reported outcomes in advanced NSCLC before and during the COVID‐19 pandemic: Real‐world data from the German prospective CRISP Registry (AIO‐TRK‐0315)

History Can Teach Us Something: Angiogenesis Inhibition Revisited

The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer

Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment-Comparison with Stage III Disease

Theranostics with somatostatin receptor antagonists in SCLC: Correlation of 68 Ga-SSO120 PET with immunohistochemistry and survival

Konzepte beim oligometastasierten Lungenkarzinom

68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study

68 Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study

IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer

Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry

Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT

Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer: focus on treatment selection and prognostic factors

Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment

Therapie früher und lokal fortgeschrittener Stadien des nicht-kleinzelligen Lungenkarzinoms

Treatment of early and locally advanced stages of non-small cell lung cancer

Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications

Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non–Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18 F-FDG PET/CT for radiotherapy target volume definition

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition

Acquired Resistance to BRAF/MEK Inhibitor Therapy in BRAF-V 600 -mutated Squamous Cell Lung Cancer: Concurrent Evolvement of PTEN and MEK1 Mutations

Acquired Resistance to BRAF/MEK Inhibitor Therapy in BRAF-V600-mutated Squamous Cell Lung Cancer: Concurrent Evolvement of PTEN and MEK1 Mutations

N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [18F]FDG PET/CT compared to the histopathology reference standard

Suchergebnisse filtern